Escolar Documentos
Profissional Documentos
Cultura Documentos
PHARMACODYNAMICS
Factors Affecting Drug Effects on the Infant:
I. Drug Absorption
II. Drug Distribution
III. Drug Metabolism
IV. Drug Excretion
Drug
Neonates t1/2
(hours)
Adults t1/2
(hours)
Acetaminophn
2.25
0.92.2
Diazepam
25100
4050
Digoxin
6070
3060
05 days
200
64140
515 days
100
130 months
50
02 days
80
314 days
18
1450 days
Phenobarbital
Phenytoin
Neonatal Age
Salicylate
Theophylline
1218
4.511
1015
Neonate
1326
1015
Child
34
Weight
(kg)
(lb)
Age
Surface
Area
(m2)
Percent of
Adult
Dose
6.6
Newborn
0.2
12
13.2
3 months
0.3
18
10
22
1 year
0.45
28
20
44
5.5 years
0.8
48
30
66
9 years
60
40
88
12 years
1.3
78
50
110
14 years
1.5
90
60
132
Adult
1.7
102
70
154
Adult
1.76
103
Drug
Effect on
Infant
Comments
Ampicillin
Minimal
Aspirin
Minimal
Caffeine
Minimal
Chloral
hydrate
Significant
Chloramphe
nicol
Significant
Thiazide
Minimal
CPZ
Minimal
Appears insignificant.
Codeine
Minimal
Diazepam
Dicumarol
Minimal
Digoxin
Minimal
Ethanol
Moderate
Heroin
Minimal
Kanamycin
Minimal
Lithium
Methadone
Significant (See heroin.) Under close physician supervision, breastfeeding can be continued. Signs of opioid
withdrawal in the infant may occur if mother stops
taking methadone or stops breast feeding abruptly.
Oral
contraceptives
Minimal
Penicillin
Minimal
Phenobarbital
Moderate
Phenytoin
Moderate
Prednisone
Moderate
Propranolol
Minimal
Propylthiouracil
Significant
Spironolactone
Minimal
Tetracycline
Moderate
Theophylline
Moderate
Thyroxine
Minimal
Tolbutamide
Minimal
Warfarin
Minimal
during Lactation:
Ergotamine
Heroin
Lithium
Marijuana
Methotrexate
Nicotine
Phenindione
Noor Wijayahadi
Therapeutic Response
Therapeutic Window
Toxic Response
Age
The Precipice
Physiologic
Reserves
Available
Physiologic
Reserves
Already In Use
Increasing Age
Masalah Utama
Pilihan obat atau dosis yang tidak tepat
Concomitant disease affect metabolism
of or response to drug
Polypharmacy drug - drug interactions
Patient behavioural factors
Perubahan PHARMACOKINETICS
Absorption
active transfer
Body composition
lean body mass
body fat
plasma albumin
Liver metabolism
oxidation / microsomal enzymes
Renal clearance
Perubahan
PHARMACODYNAMICS
Brain sensitivity
Benzodiazepines and
Thermoregulation
hypothermia
COMMON PITFALLS 1 :
Gagal mengobati kondisi yang seharusnya
bisa diobati (treatable conditions)
Thrombolytic therapy
the older the patient, the greater the benefit
the older the patient, the less likely to be
thrombolysed
Hypertension
30 - 40% decrease in risk of CVA if ISH treated
40
50
60
70
80
COMMON PITFALLS 2 :
Prescribing for symptom and not for
diagnosis
PRESCRIPTIONS BY AGE
(Items per person per year)
40
35
30
25
20
15
10
5
0
42 46 50 54 58 62 66 70 74 78 82 86 90
EFFECTIVE PRESCRIBING 1
Utamakan non-pharmalogical treatment
modify diet
stop smoking, reduce alcohol
physical exercise
walking aids, household adaptations
social supports
EFFECTIVE PRESCRIBING 2
Treat conditions in order of priority
Pertimbangkan kegagalan fungsi organ
Start low mulai dosis kecil , naikkan
dengan hati-hati
Gunakan formularium yang terbatas
Monitor compliance and response
Review pemakaian obat secara reguler
Ikut sertakan PENDERITA
Umur mempengaruhi
metabolisme obat?
Pada manula:
Slower organ function
Slower blood circulation
Increased body fat
Age-Related Changes:
Total body water menurun konsentrasi dalam
darah obat yang larut-air meningkat
Perubahan berat badan mempengaruhi dosis
yang diperlukan dan lama obat dalam tubuh:
More body fat prolonged half-life
Less lean body mass increased drug concentration
Age-Related Changes:
Slower circulation delay drugs getting
to liver and kidneys
Slow down of liver and kidneys affects
time it takes for medication to break down
and leave body
Less absorption from transdermal patches
Drug receptor sites may be different in
older adults
Changes in Pharmacokinetics
Perubahan fisiologis dan fungsi organ pada
manula perubahan Farmakokinetik
Pharmacokinetics is the time course of a drug
and its metabolites through the body
Absorption
Distribution
Clearance: elimination (renal), metabolism (liver)
Protein Binding
albumin berkurang chronic disease:
e.g.,malnutrition, liver or kidney conditions.
obat dengan ikatan protein tinggi kadar
obat bebas meningkat.
ceftriaxone,diazepam, phenytoin,
warfarin.
Inducers
Allopurinol
Metronidazole
Barbiturates
Amiodorone
Quinolones
Carbamazepine
Azole antifungals
Phenytoin
Cimetidine
Rifampin
INH
Tobacco
SSRIs
Tacrine
Hepatic Metabolism
Decreased liver size and hepatic blood flow.
Regional blood flow to the liver at age 65 is reduce
by 40-45% compared to a 25 year old.
Metabolic clearance of drugs by the liver may be
reduced.
Disease effects: liver congestion from heart failure
decreases warfarin metabolism and an increased
pharmacologic response.
Environmental effects: smoking stimulates
monoxygenase enzymes and increases clearance
of theophylline.
Changes in Pharmacodynamics
Older patients may have more sedation and
impaired function after a single dose of
benzodiazepines than younger persons.
After single dose of nitrazepam older patients
made more mistakes on psychomotor testing
compared to placebo while younger patients
had no impairment .
Suboptimal Quality
Typology of Quality Problems:
Overuse (Polypharmacy)
Underuse
Misuse (Inappropriate Prescribing)
Errors
Suboptimal Prescribing
Polypharmacy
Underuse of Effective Medications
Drug-Drug Interactions
Drug-Disease Interactions
Inadequate Monitoring
Inappropriate Dosing
Inappropriate Duration
Drugs to Avoid
Drug-Drug Interactions
Penyebab tersering ESO pada manula
Jumlahnya sangat banyak Almost
countless peresepan elektronik
Some common examples
Drug-disease Interactions
Patient with PD have increased risk of drug
induced confusion
NSAIA (and COX-2s) s can exacerbate CHF
Urinary retention in BPH patients on
decongestants or anticholinergics
Constipation worsened by calcium,
ahticholinergics, calcium channel blockers
Neuroleptics and quinolones lower seizure
thresholds
Polypharmacy
Polypharmacy = pemberian banyak
obat melebihi indikasi penggunaan
59% manula mendapat obat tanpa
indikasi yang jelas.
55% manula mendapat obat tanpa
indikasi, 32.7% mendapat obat yang
tidak efektif, 16.8% mendapat obat
duplikasi
2001: Hanlon, JAGS
Underuse
Among patients elderly patients with
cardiovascular disease and diabetes, only
19.1% of patients were prescribed statins. In
patients 66 to 74 years old, the adjusted
probabilities of statin prescription were 37.7%,
26.7%, and 23.4% in the categories of low,
intermediate, and high baseline risk,
respectively.
The likelihood of statin prescription was 6.4%
lower (adjusted odds ratio, 0.94; 95%
confidence interval, 0.93-0.95) for each year of
increase in age and each 1% increase in
2004: Ko, JAMA
predicted
3-year mortality risk.
Inappropriate Prescribing
20-27% manula mendapat resep yang
tidak diperlukan (inappropriate).
Inappropriate prescribing meningkatkan
resiko jatuh, fraktur femur, cognitive
impairment, diminished independence,
dan mortalitas
Belladonna alkaloids
Dicyclomine
Hyoscyamine
Propantheline
Trimethobenzamide
Tangga Peresepan
(Prescribing Cascade)
The prescribing cascade terjadi
bila satu obat diresepkan,
Menyebabkan timbulnya
efek samping obat / adverse
drug event (ADE),
Mendorong peresepan obat
kedua untuk mengatasi ESO
sebelumnya
Drug 1
ADE
Drug 2
Extrapyramidal Effects
Levodopa Rx
Avorn J et al, JAMA 1995
Blood Pressure
Antihypertensive Rx
Drug-Food Interactions
Interactions between drugs and food
warfarin and Vitamin K containing foods
(remember green tea, as well)
Phenytoin & vitamin D metabolism
Methotrexate and folate metabolism
Steroids
Think about osteoporosis prevention
Remember steroid induced diabetes
Levothyroxine
Calcium interferes with absorption of levothyroxine
Drug Discrepancies
Difference between medical record and
medication bottles in 76% of cases
51% of time medication not recorded
29% medication recorded that patient not
taking
20% dosage discrepancy
Nonadherence
Lack of understanding of how to take
High risk times: Hospital discharge, new meds
added, complex regimens
Unable to take
Conscious nonadherence
Side effects
Lack of understanding of benefits of drug
Financial
Complementary Therapies
Very commonly used in the elderly
Some common herbs and alternative therapies:
Anti-aging
Dementia
BPH
OA
Depression
Adulterants in Products
California Department of Health
Services, Food and Drug Branch
screened 250 Asian herbal products
collected from herbal stores in California
assayed products using gas chromatography,
mass spectrometry, and atomic-absorption
techniques
Ko, NEJM 1998; 339; 847
Principles (continued)
Pertimbangkan pemakaian kotak obat harian
atau mediset
Hentikan pemakaian obat yang tidak jelas
keuntungannya atau resiko efek sampingnya
lebih merugikan
Hati-hati pemakaian obat baru (newer drugs)
Hindari penggunaan obat > 5 macam
Consider if the benefit of the 7th or 8th drug is
sufficient to justify the cost, increase in
complexity of regimen, and risk of side effects
Newer drugs
What is unique about this compound?
What clinical data is available?
How does it compare with traditional
therapy?
How expensive is it?
With third party payers cover this
product?
Does the potential advantage of this new
drug justify the risk of using a new drug?